Drug slows Alzheimer's but can it make a real difference? - Smithers Interior News
Lecanemab delayed patients’ worsening by about five months over the course of the 18-month study
Source: interior-news.com
Stay updated with breaking news from Ron Petersen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Lecanemab delayed patients’ worsening by about five months over the course of the 18-month study
Lecanemab delayed patients’ worsening by about five months over the course of the 18-month study
Lecanemab delayed patients’ worsening by about five months over the course of the 18-month study
Lecanemab delayed patients’ worsening by about five months over the course of the 18-month study
Lecanemab delayed patients’ worsening by about five months over the course of the 18-month study